Steven J. O'Day's Insider Trades & SAST Disclosures
Steven J. O'Day's most recent trade in Agenus Inc was a trade of 50,000 Stock Option done . Disclosure was reported to the exchange on Nov. 14, 2024.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Steven J. O'Day.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Agenus Inc | Steven J. O'Day | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Nov 2024 | 50,000 | 50,000 | - | - | Stock Option | |
| Agenus Inc | Steven J. O'Day | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jun 2024 | 37,907 | 37,907 | - | - | Stock Option | |
| Agenus Inc | Steven J. O'Day | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jun 2024 | 10,000 | 10,000 | - | - | Stock Option | |
| Agenus Inc | Steven J. O'Day | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2023 | 200,000 | 200,000 | - | - | Stock Option | |
| Agenus Inc | Steven J. O'Day | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 2.45 per share. | 05 Jan 2023 | 109,381 | 272,384 (0%) | 0% | 2.4 | 267,983 | Common Stock |
| Agenus Inc | Steven J. O'Day | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 2.51 per share. | 02 Feb 2022 | 101,682 | 163,003 (0%) | 0% | 2.5 | 255,222 | Common Stock |
| Agenus Inc | Steven J. O'Day | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Jan 2022 | 100,000 | 0 | - | - | Restricted Stock Units | |
| Agenus Inc | Steven J. O'Day | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Jan 2022 | 100,000 | 100,000 (0%) | 0% | - | Common Stock | |
| Agenus Inc | Steven J. O'Day | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 3.06 per share. | 04 Jan 2022 | 38,679 | 61,321 (0%) | 0% | 3.1 | 118,346 | Common Stock |
| Agenus Inc | Steven J. O'Day | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2022 | 150,000 | 150,000 | - | - | Stock Option (Right to Buy) |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges